Neuropsychiatric biomarker discovery: go big or go home

Trends Mol Med. 2023 Sep 13:S1471-4914(23)00217-4. doi: 10.1016/j.molmed.2023.09.002. Online ahead of print.ABSTRACTTechnological advances have enabled high-throughput omics assays, such as parallelized screening of lipids across plasma samples. Pioneering a new paradigm for neuropsychiatric biomarker discovery, Yap et al. describe a large-scale systematic analysis of comprehensive phenotypic, genotypic, environmental, and lipidomic data to unravel the intricate interplay between these and autism-associated traits.PMID:37714797 | DOI:10.1016/j.molmed.2023.09.002
Source: Trends in Molecular Medicine - Category: Molecular Biology Authors: Source Type: research